Etravirine

In the US, Etravirine (etravirine systemic) is a member of the drug class NNRTIs and is used to treat HIV Infection.

US matches:

• Etravirine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AG04

CAS registry number (Chemical Abstracts Service)

0269055-15-4

Chemical Formula

C20-H15-Br-N6-O

Molecular Weight

435

Therapeutic Category

Antiviral agent, HIV reverse transcriptase inhibitor

Chemical Name

4-[6-Amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yloxy]-3,5-dimethylbenzonitrile (WHO)

Foreign Names

• Etravirinum (Latin)
• Etravirin (German)
• Étravirine (French)
• Etravirina (Spanish)

Generic Names

• Etravirine (OS: USAN)
• R-165335 (IS)
• TMC-125 (IS: Tibotec)

Brand Names

• Intelence
  Janssen, Australia; Janssen, Germany; Janssen, Spain; Janssen, Ireland; Janssen, Luxembourg; Janssen-Cilag, Switzerland; Janssen-Cilag, France; Janssen-Cilag, United Kingdom; Janssen-Cilag, Sweden; Janssen-Cilag International, Austria; Janssen-Ortho Inc., Canada; Tibotec, United States



• TMC125
  Janssen-Cilag, France

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.